These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28082208)

  • 1. Body composition and clinical outcome measures in patients with myotonic dystrophy type 1.
    Sedehizadeh S; Brook JD; Maddison P
    Neuromuscul Disord; 2017 Mar; 27(3):286-289. PubMed ID: 28082208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional body composition and functional impairment in patients with myotonic dystrophy.
    Pruna L; Chatelin J; Pascal-Vigneron V; Kaminsky P
    Muscle Nerve; 2011 Oct; 44(4):503-8. PubMed ID: 21826679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body composition analysis in patients with myotonic dystrophy types 1 and 2.
    Peric S; Bozovic I; Nisic T; Banovic M; Vujnic M; Svabic T; Pesovic J; Brankovic M; Basta I; Jankovic M; Savic-Pavicevic D; Rakocevic-Stojanovic V
    Neurol Sci; 2019 May; 40(5):1035-1040. PubMed ID: 30790082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional impairment in patients with myotonic dystrophy type 1 can be assessed by an ataxia rating scale (SARA).
    DiPaolo G; Jimenez-Moreno C; Nikolenko N; Atalaia A; Monckton DG; Guglieri M; Lochmüller H
    J Neurol; 2017 Apr; 264(4):701-708. PubMed ID: 28168524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Energy Expenditure, Body Composition, and Skeletal Muscle Oxidative Capacity in Patients with Myotonic Dystrophy Type 1.
    Joosten IBT; Fuchs CJ; Beelen M; Plasqui G; van Loon LJC; Faber CG
    J Neuromuscul Dis; 2023; 10(4):701-712. PubMed ID: 37154183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive behaviour therapy plus aerobic exercise training to increase activity in patients with myotonic dystrophy type 1 (DM1) compared to usual care (OPTIMISTIC): study protocol for randomised controlled trial.
    van Engelen B;
    Trials; 2015 May; 16():224. PubMed ID: 26002596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI of trunk muscles and motor and respiratory function in patients with myotonic dystrophy type 1.
    Solbakken G; Bjørnarå B; Kirkhus E; Nguyen B; Hansen G; Frich JC; Ørstavik K
    BMC Neurol; 2019 Jun; 19(1):135. PubMed ID: 31216995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Outcome Evaluations and CBT Response Prediction in Myotonic Dystrophy.
    van As D; Okkersen K; Bassez G; Schoser B; Lochmüller H; Glennon JC; Knoop H; van Engelen BGM; 't Hoen PAC;
    J Neuromuscul Dis; 2021; 8(6):1031-1046. PubMed ID: 34250945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of body composition, metabolism, and pulmonary function in patients with myotonic dystrophy type 1.
    Kikuchi K; Satake M; Furukawa Y; Terui Y
    Medicine (Baltimore); 2022 Sep; 101(36):e30412. PubMed ID: 36086756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major involvement of trunk muscles in myotonic dystrophy type 1.
    Solbakken G; Ørstavik K; Hagen T; Dietrichs E; Naerland T
    Acta Neurol Scand; 2016 Dec; 134(6):467-473. PubMed ID: 26984572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative muscle MRI as a sensitive marker of early muscle pathology in myotonic dystrophy type 1.
    van der Plas E; Gutmann L; Thedens D; Shields RK; Langbehn K; Guo Z; Sonka M; Nopoulos P
    Muscle Nerve; 2021 Apr; 63(4):553-562. PubMed ID: 33462896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to capture activities of daily living in myotonic dystrophy type 2?
    Montagnese F; Rastelli E; Stahl K; Massa R; Schoser B
    Neuromuscul Disord; 2020 Oct; 30(10):796-806. PubMed ID: 32888768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower limb muscle strength impairment in late-onset and adult myotonic dystrophy type 1 phenotypes.
    Petitclerc É; Hébert LJ; Mathieu J; Desrosiers J; Gagnon C
    Muscle Nerve; 2017 Jul; 56(1):57-63. PubMed ID: 27784130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myotonic dystrophy health index: Correlations with clinical tests and patient function.
    Heatwole C; Bode R; Johnson NE; Dekdebrun J; Dilek N; Eichinger K; Hilbert JE; Logigian E; Luebbe E; Martens W; Mcdermott MP; Pandya S; Puwanant A; Rothrock N; Thornton C; Vickrey BG; Victorson D; Moxley RT
    Muscle Nerve; 2016 Feb; 53(2):183-90. PubMed ID: 26044513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of muscle strength assessed with handheld dynamometers as a non-invasive biological marker in myotonic dystrophy type 1 patients: a multicenter study.
    Hébert LJ; Remec JF; Saulnier J; Vial C; Puymirat J
    BMC Musculoskelet Disord; 2010 Apr; 11():72. PubMed ID: 20398425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary titin in myotonic dystrophy type 1.
    Varga D; Perecz B; Fülöp K; Sipos A; Janszky JV; Hajdú N; Pál E
    Muscle Nerve; 2023 Aug; 68(2):215-218. PubMed ID: 37291994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postabsorptive and insulin-stimulated energy and protein metabolism in patients with myotonic dystrophy type 1.
    Perseghin G; Comola M; Scifo P; Benedini S; De Cobelli F; Lanzi R; Costantino F; Lattuada G; Battezzati A; Del Maschio A; Luzi L
    Am J Clin Nutr; 2004 Aug; 80(2):357-64. PubMed ID: 15277156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of patient-reported outcome measures for use in myotonic dystrophy type 1 patients.
    Symonds T; Randall JA; Campbell P
    Muscle Nerve; 2017 Jul; 56(1):86-92. PubMed ID: 27862031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of muscular strength and functional capacity in the juvenile and adult myotonic dystrophy type 1 population: a 3-year follow-up study.
    Roussel MP; Fiset MM; Gauthier L; Lavoie C; McNicoll É; Pouliot L; Gagnon C; Duchesne E
    J Neurol; 2021 Nov; 268(11):4221-4237. PubMed ID: 33907889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is one trial enough for repeated testing? Same-day assessments of walking, mobility and fine hand use in people with myotonic dystrophy type 1.
    Kierkegaard M; Petitclerc E; Hébert LJ; Gagnon C
    Neuromuscul Disord; 2017 Feb; 27(2):153-158. PubMed ID: 28062219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.